Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of NNC0662-0419 with Oral Contraceptive and Acetaminophen in Overweight or Obese Women
NCT07525791Phase 1Active, not recruiting
- Sponsor
- Novo Nordisk
- Start
- Apr 2026
- Primary completion
- May 2027
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of NNC0662-0419 in obesity, sponsored by Novo Nordisk. Primary endpoints: Area under the ethinyl estradiol plasma concentration-time curve and Area under the levonorgestrel plasma concentration-time curve. Started Apr 2026; status: active, not recruiting.
02
Drugs
NNC0662-0419
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07525791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07525791.